PerpEquities

BioNTech SE (BNTX) balance sheet

NASDAQ · Healthcare · Biotechnology · 7,807 employees · CEO Ugur Sahin

Price
$88.17 -1.08%
Market cap
$22.1B
Enterprise value
€10.2B
Last report
Q2 '26 filed 2026-08-04
Next report
2026-11-03

At the end of Q2 '26 BioNTech SE (BNTX) held €9.74B in cash and short-term investments against €316M of debt incl. leases. Total assets €20.3B, total liabilities €2.58B, shareholders' equity €17.8B.

Balance sheet

Balance sheetTrendQ3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Assets
Cash & equivalents€13.5B€11.7B€8.98B€10.4B€9.62B€9.76B€10.2B€10.3B€10.1B€7.67B€9.95B€9.74B
Short-term investments€2.25B€4.89B€6.69B€6.92B€7.08B€7.02B€3.92B€3.77B€4.43B€7.16B€4.7B€0
Receivables€2.01B€2.16B€1.93B€287M€1.2B€1.52B€1.03B€1.45B€700M€984M€613M€245M
Inventory€416M€358M€345M€340M€303M€283M€254M€231M€226M€111M€104M€101M
Other current assets€576M€460M€337M€359M€276M€213M€234M€215M€378M€211M€179M€5.21B
Current assets€18.7B€19.5B€18.3B€18.3B€18.5B€18.8B€15.6B€15.9B€15.8B€16.1B€15.5B€15.3B
Property, plant & equipment (net)€926M€972M€1.03B€1.13B€1.16B€1.18B€1.27B€1.24B€1.24B€1.29B€1.32B€1.22B
Long-term investments€1.29B€1.18B€1.59B€1.39B€1.33B€1.25B€2.29B€2.5B€2.48B€2.49B€2.28B€2.01B
Goodwill€366M€363M€369M€372M€374M€381M€376M€364M€358M€368M€371M€373M
Intangible assets€666M€782M€822M€862M€874M€790M€1.51B€1.49B€1.39B€1.61B€1.55B€1.42B
Deferred tax assets€0€0€91M€102M€90.7M€81.7M€85.5M€77.8M€0€13.5M€14.7M€15.7M
Other non-current assets€208M€187M€83.2M€108M€84.8M€36.1M€30.5M€32.7M€46.2M€77M€12.2M€10.3M
Non-current assets€3.46B€3.48B€3.98B€3.96B€3.92B€3.73B€5.56B€5.71B€5.51B€5.84B€5.55B€5.04B
Total assets€22.2B€23B€22.3B€22.2B€22.4B€22.5B€21.2B€21.6B€21.3B€22B€21.1B€20.3B
Liabilities
Accounts payable€223M€354M€299M€882M€763M€427M€444M€504M€400M€535M€469M€646M
Short-term debt€2.2M€0€31.3M€35.3M€37.4M€39.5M€55.5M€52.4M€13.2M€52.2M€56.8M€57.2M
Taxes payable€0€0€353M€365M€364M€4.5M€5.4M€3.7M€0€0€0€0
Deferred revenue€0€0€361M€474M€236M€295M€295M€945M€0€755M€759M€742M
Other current liabilities€1.54B€1.69B€561M€670M€1.12B€1.76B€735M€345M€1.77B€734M€443M€481M
Current liabilities€1.81B€2.07B€1.61B€2.43B€2.52B€2.52B€1.53B€1.85B€2.22B€2.14B€1.77B€1.95B
Long-term debt€0€2.4M€205M€219M€206M€215M€238M€217M€25.2M€29.9M€0€259M
Lease obligations (non-current)€162M€189M€0€0€0€0€0€0€167M€185M€246M€0
Deferred revenue (non-current)€0€0€379M€354M€377M€183M€183M€788M€0€88M€87.8M€87.6M
Deferred tax liabilities€0€0€39.4M€37.8M€37.8M€42.4M€44.1M€28.5M€0€84.3M€53M€33.3M
Other non-current liabilities€371M€499M€59M€129M€143M€155M€257M€248M€449M€235M€225M€256M
Non-current liabilities€533M€690M€683M€740M€764M€595M€721M€1.28B€641M€622M€612M€636M
Total liabilities€2.34B€2.76B€2.29B€3.17B€3.29B€3.12B€2.26B€3.13B€2.86B€2.76B€2.38B€2.58B
Equity
Common stock & paid-in capital€249M€249M€249M€249M€249M€249M€249M€249M€249M€259M€259M€259M
Retained earnings€19.3B€19.8B€19.4B€18.6B€18.8B€19.1B€18.7B€18.3B€18.3B€18B€17.4B€16.6B
Accumulated other comprehensive income€324M€245M-€947M-€1.04B-€1.34B-€1.33B-€1.44B-€1.48B-€30.1M-€1.46B-€1.45B€0
Shareholders' equity€19.9B€20.2B€20B€19.1B€19.1B€19.4B€18.9B€18.5B€18.5B€19.2B€18.7B€17.8B
Debt
Total debt (incl. leases)€202M€219M€236M€255M€244M€254M€293M€270M€245M€267M€303M€316M
Net debt (debt - cash)-€13.3B-€11.4B-€8.74B-€10.1B-€9.38B-€9.51B-€9.89B-€10B-€9.85B-€7.4B-€9.65B-€9.42B

Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in EUR.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings.

Data as of 2026-11-02 · Amounts in EUR as reported; price and market cap in USD.